FN1 and rheumatoid arthritis: In the CIA model, scFv 31 appeared to prevent arthritic damage by inhibiting loss of articular cartilage and synovial hypertrophy, decreasing fibronectin polymerization, and expressing proinflammatory cytokines related to RA [162].